Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_assertion type Assertion NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_head.
- NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_assertion description "[The frequencies of the ACE DD, ID, and II genotypes were 34.8%, 37.0%, and 28.3%, respectively, among type 2 diabetic patients with nephropathy, and 33.9%, 42.9%, 23.2%, respectively (P=.788), in the control subjects without diabetic nephropathy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_provenance.
- NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_assertion evidence source_evidence_literature NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_provenance.
- NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_assertion SIO_000772 18413162 NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_provenance.
- NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_assertion wasDerivedFrom befree-2016 NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_provenance.
- NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_assertion wasGeneratedBy ECO_0000203 NP665788.RAJ6uZx9FVyjniPHVsmGI8Q45wUmB2UZTHNQiqK7NQKvg130_provenance.